Cargando…
Immunological responses to a multi-peptide vaccine targeting cancer-testis antigens and VEGFRs in advanced pancreatic cancer patients
The prognosis of patients with advanced pancreatic cancer is extremely poor and there are only a few standard treatments. Here, we report the results of a Phase I clinical trial to investigate the safety, immunostimulatory effects, and antineoplastic activity of a multi-target vaccine composed of fo...
Autores principales: | Okuyama, Ryuji, Aruga, Atsushi, Hatori, Takashi, Takeda, Kazuyoshi, Yamamoto, Masakazu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906430/ https://www.ncbi.nlm.nih.gov/pubmed/24498547 http://dx.doi.org/10.4161/onci.27010 |
Ejemplares similares
-
Phase I clinical trial of multiple-peptide vaccination for patients with advanced biliary tract cancer
por: Aruga, Atsushi, et al.
Publicado: (2014) -
Vaccination of biliary tract cancer patients with four peptides derived from cancer-testis antigens
por: Aruga, Atsushi
Publicado: (2013) -
Multiple therapeutic peptide vaccines consisting of combined novel cancer testis antigens and anti-angiogenic peptides for patients with non-small cell lung cancer
por: Suzuki, Hiroyuki, et al.
Publicado: (2013) -
Cancer testis antigens and genomic instability: More than immunology(,)
por: Jay, Ash, et al.
Publicado: (2021) -
RT-qPCR analysis of the tumor antigens TOMM34 and RNF43 in samples extracted from paraffin-embedded specimens of colorectal cancer
por: Matsushita, Norimasa, et al.
Publicado: (2017)